Vontobel Holding Ltd. Travere Therapeutics, Inc. Transaction History

Vontobel Holding Ltd.

  • $27.3 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$7.18 - $9.82 $1.97 Million - $2.7 Million
-274,623 Reduced 95.55%
12,800 $98,000
Q4 2023

Jun 03, 2024
BUY
$5.44 - $9.5 $1.49 Million - $2.61 Million
274,623 Added 2145.49%
287,423 $2.58 Million
Q4 2023

Jan 29, 2024
BUY
$5.44 - $9.5 $1.56 Million - $2.73 Million
287,423 New
287,423 $2.58 Million

Others Institutions Holding TVTX

# of Institutions
214
Shares Held
94.3M
Call Options Held
1.2M
Put Options Held
778K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.34B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email